{
    "nct_id": "NCT06376669",
    "official_title": "Prospective Phase II Study of Stereotactic Body Proton Therapy for Treatment of PrimAry Renal Cell Carcinoma (SPARE)",
    "inclusion_criteria": "1. Age â‰¥ 18 years\n2. Biopsy proven renal cell carcinoma.\n3. No clinical or radiographic evidence of metastatic disease.\n4. Not a candidate for surgical treatment or local ablative procedures.\n5. Subjects are able to undergo either an MRI or administration of contrast agent for CT.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Prior history of radiation treatment with overlapping fields.\n2. Patients with proven metastatic disease.\n3. Female subjects who are pregnant or planning to become pregnant during the treatment.",
    "miscellaneous_criteria": ""
}